drugset / Trial / NCT02203331

Bay98-7196, Dose Finding / POC Study

NCT02203331

Phase 2 Completed 319 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain

Timeline

Start
2014-10-16
Primary completion
2016-10-24
Completion
2016-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 300 ug Other
Subject Anastrozole Other / unclassified 600 ug Other
Subject Anastrozole Other / unclassified 1050 ug Other
Comparator Leuprolide Other / unclassified 11.25 mg Intramuscular
Subject Levonorgestrel Small molecule 40 ug Other

Indications